Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
2023 | U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
U.S. STEM CELL, INC. | Bio Therapeutic Drugs | +9,900.00% | -.--% | - | -95.24% | -99.44% | 66.15K | - | - | - |
- Stock Market
- Equities
- USRM Stock
- Charts U.S. Stem Cell, Inc.
- Relative Strength Chart